How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,981 results for

Alpha Adrenergic Central Agonist

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Do ?2-Adrenergic Agonists Decrease the Symptoms Associated With Opioid Withdrawal? Full Text available with Trip Pro

Commentator) Department of Emergency Medicine, Rush University Medical Center, Chicago, IL DOI: | Publication History Published online: November 04, 2016 Expand all Collapse all Article Outline Take-Home Message α 2 -Adrenergic agonists (eg, clonidine) are associated with lower rates of severe withdrawal symptoms and higher rates of adherence; however, this must be balanced with known adverse effects such as hypotension. Methods Data Sources Electronic searches were performed with the Cochrane Central (...) Do ?2-Adrenergic Agonists Decrease the Symptoms Associated With Opioid Withdrawal? Do α2-Adrenergic Agonists Decrease the Symptoms Associated With Opioid Withdrawal? - Annals of Emergency Medicine Email/Username: Password: Remember me Search Terms Search within Search Share this page Access provided by Volume 69, Issue 6, Pages 740–742 Do α 2 -Adrenergic Agonists Decrease the Symptoms Associated With Opioid Withdrawal? x Michael Gottlieb , MD (EBEM Commentator) , x Katarzyna Gore , MD (EBEM

2017 Annals of Emergency Medicine Systematic Review Snapshots

2. Alpha Adrenergic Central Agonist

Alpha Adrenergic Central Agonist Alpha Adrenergic Central Agonist Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Alpha Adrenergic (...) Central Agonist Alpha Adrenergic Central Agonist Aka: Alpha Adrenergic Central Agonist , Central Adrenergic Agonist , Methyl-Dopa , Methyldopa , Aldomet , Guanabenz , Wytensin From Related Chapters II. Mechanism See Bind vasomotor receptors to inhibit sympathetic outflow Decreases peripheral vascular resistance (and ) Decreases III. Preparations ( ) Methyl-Dopa (Aldomet) Guanabenz (Wytensin) Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search

2018 FP Notebook

3. Alpha 2 Agonists for Sedation to Produce Better Outcomes From Critical Illness (A2B Trial)

table for additional information Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No Product Manufactured in and Exported from the U.S.: No Keywords provided by University of Edinburgh: Sedation Ventilation Additional relevant MeSH terms: Layout table for MeSH terms Critical Illness Disease Attributes Pathologic Processes Propofol Dexmedetomidine Clonidine Adrenergic alpha-2 Receptor Agonists Hypnotics and Sedatives Central Nervous System Depressants (...) Physiological Effects of Drugs Anesthetics, Intravenous Anesthetics, General Anesthetics Analgesics, Non-Narcotic Analgesics Sensory System Agents Peripheral Nervous System Agents Adrenergic alpha-Agonists Adrenergic Agonists Adrenergic Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Antihypertensive Agents Sympatholytics Autonomic Agents

2018 Clinical Trials

4. Alpha Adrenergic Central Agonist

Alpha Adrenergic Central Agonist Alpha Adrenergic Central Agonist Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Alpha Adrenergic (...) Central Agonist Alpha Adrenergic Central Agonist Aka: Alpha Adrenergic Central Agonist , Central Adrenergic Agonist , Methyl-Dopa , Methyldopa , Aldomet , Guanabenz , Wytensin From Related Chapters II. Mechanism See Bind vasomotor receptors to inhibit sympathetic outflow Decreases peripheral vascular resistance (and ) Decreases III. Preparations ( ) Methyl-Dopa (Aldomet) Guanabenz (Wytensin) Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search

2015 FP Notebook

5. Alpha Adrenergic Receptor

muscle postsynaptic s striction Positive Inotrope Negative Chronotrope Eye Radial muscle contraction Gastrointestinal and Genitourinary Sphincter (e.g. anus) contraction IV. Effects: Alpha 2 Receptors Peripheral Alpha 2 Receptors Vascular Smooth Muscle (mixed effect) Modulates large vessel tone Arteriolar and venous striction Opposes alpha 1 receptor striction Inhibits release Decreases adrenergic activity Gastrointestinal Smooth muscle wall relaxation Metabolic Fat Cell Lipolysis Central Alpha 2 (...) Receptors (CNS) Inhibits Locus Ceruleus reflex arc Peripheral vasodilatation V. Medications: Alpha Adrenergics Alpha Adrenergic Agonist (Alpha Adrenergic Receptor) Alpha Non-Specific Alpha 1 Selective Methoxamine Alpha 2 Selective (See ) Alpha-methylnorepinephrine Alpha Receptor Antagonist Alpha Non-Specific Phentolamine Alpha 1 Selective (See ) Phenoxybenzamine Alpha 2 Selective Tolazoline Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search

2018 FP Notebook

6. Treatment of OSA Associated Hypertension With Alpha 2 Agonist or Diuretic

Apnea, Obstructive Vascular Diseases Cardiovascular Diseases Apnea Respiration Disorders Respiratory Tract Diseases Sleep Disorders, Intrinsic Dyssomnias Sleep Wake Disorders Nervous System Diseases Hydrochlorothiazide Guanfacine Antihypertensive Agents Diuretics Natriuretic Agents Physiological Effects of Drugs Sodium Chloride Symporter Inhibitors Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Adrenergic alpha-2 Receptor Agonists Adrenergic alpha-Agonists Adrenergic (...) Treatment of OSA Associated Hypertension With Alpha 2 Agonist or Diuretic Treatment of OSA Associated Hypertension With Alpha 2 Agonist or Diuretic - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Treatment

2016 Clinical Trials

7. Beta Adrenergic Receptor

. Related Studies (from Trip Database) Ontology: Receptors, Adrenergic, beta-1 (C0001642) Definition (MSH) A subclass of beta-adrenergic receptors (RECEPTORS, ADRENERGIC, BETA). The adrenergic beta-1 receptors are equally sensitive to EPINEPHRINE and NOREPINEPHRINE and bind the agonist DOBUTAMINE and the antagonist METOPROLOL with high affinity. They are found in the HEART, juxtaglomerular cells, and in the central and peripheral nervous systems. Definition (NCI) Beta 1 adrenergic receptor protein (477 (...) . Medications: Beta Adrenergics Beta Adrenergic Agonist (Beta Adrenergic Receptor) Beta Non-Specific Beta 1 Selective Prenalterol Beta 2 Selective (See ) Fenoterol Metaproterenol Beta Non-specific Pindolol Beta 1 Selective Acebutolol Alprenolol Beta 2 Selective Butoxamine Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Beta Adrenergic Receptor." Click on the image (or right click) to open the source website in a new browser window

2018 FP Notebook

8. Alpha Adrenergic Receptor

muscle postsynaptic s striction Positive Inotrope Negative Chronotrope Eye Radial muscle contraction Gastrointestinal and Genitourinary Sphincter (e.g. anus) contraction IV. Effects: Alpha 2 Receptors Peripheral Alpha 2 Receptors Vascular Smooth Muscle (mixed effect) Modulates large vessel tone Arteriolar and venous striction Opposes alpha 1 receptor striction Inhibits release Decreases adrenergic activity Gastrointestinal Smooth muscle wall relaxation Metabolic Fat Cell Lipolysis Central Alpha 2 (...) Receptors (CNS) Inhibits Locus Ceruleus reflex arc Peripheral vasodilatation V. Medications: Alpha Adrenergics Alpha Adrenergic Agonist (Alpha Adrenergic Receptor) Alpha Non-Specific Alpha 1 Selective Methoxamine Alpha 2 Selective (See ) Alpha-methylnorepinephrine Alpha Receptor Antagonist Alpha Non-Specific Phentolamine Alpha 1 Selective (See ) Phenoxybenzamine Alpha 2 Selective Tolazoline Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search

2015 FP Notebook

9. Hypothalamic Alpha- and Beta-Adrenergic Systems Regulate Both Thirst and Hunger in the Rat Full Text available with Trip Pro

Hypothalamic Alpha- and Beta-Adrenergic Systems Regulate Both Thirst and Hunger in the Rat Adrenergic and adrenolytic drugs were injected directly into the hypothalamus of the rat brain through permanently implanted cannulas and were found to have reliable effects on water consumption in water-satiated and water-deprived subjects. The beta-adrenergic agonist stimulated thirst, and the beta-adrenergic blocker suppressed thirst. Conversely, the alpha-adrenergic agonist suppressed thirst (...) a neurochemical explanation for the ability of organisms to maintain food and water consumption at a constant ratio. In the regulation of both hunger and thirst, the central cholinergic system mimics the hypothalamic beta-adrenergic system and opposes the hypothalamic alpha-adrenergic system.

1971 Proceedings of the National Academy of Sciences of the United States of America

10. Central cholinergic and adrenergic mechanisms in the release of antidiuretic hormone Full Text available with Trip Pro

Central cholinergic and adrenergic mechanisms in the release of antidiuretic hormone 1. Studies on the urine outflow, blood ADH concentration and electrolyte excretion were carried out in alpha-chloralose anaesthetized hydrated dogs; the agonists and antagonists of specific cholinoceptors and adrenoceptors were injected by the intracerebroventricular technique, to delineate the role of the C.N.S. receptors in the control of ADH secretion.2. Central injection of acetylcholine elicited a dose (...) -dependent antidiuretic response which was associated with an increase in the blood ADH titre. Central atropinization partially blocked the antidiuretic response. The remaining antidiuretic response was reversed to a diuretic one by further pretreatment with phenoxybenzamine. The diuretic response thus obtained could be blocked by propranolol.3. The alpha-adrenoceptor agonists, phenylephrine and noradrenaline, induced dose-dependent antidiuretic responses with a concomitant rise in blood ADH

1972 British journal of pharmacology

11. Evaluation of Bromocriptine, Metoprolol and Tamsulosin in Eyes With Non-Central DME

System Agents Physiological Effects of Drugs Adrenergic beta-1 Receptor Antagonists Adrenergic beta-Antagonists Adrenergic Antagonists Adrenergic Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Adrenergic alpha-1 Receptor Antagonists Adrenergic alpha-Antagonists Urological Agents Antiparkinson Agents Anti-Dyskinesia Agents Hormone Antagonists Hormones, Hormone Substitutes, and Hormone Antagonists Dopamine Agonists Dopamine Agents (...) Evaluation of Bromocriptine, Metoprolol and Tamsulosin in Eyes With Non-Central DME Evaluation of Bromocriptine, Metoprolol and Tamsulosin in Eyes With Non-Central DME - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before

2017 Clinical Trials

12. Central and Cerebral Circulation in Early Stages After LVAD Implantation

for additional information Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No Keywords provided by Bjorn Reinsfelt, Sahlgrenska University Hospital, Sweden: Left Ventricular Assist Device Hemodynamic monitoring Additional relevant MeSH terms: Layout table for MeSH terms Heart Failure Heart Diseases Cardiovascular Diseases Norepinephrine Adrenergic alpha-Agonists Adrenergic Agonists Adrenergic Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological (...) Central and Cerebral Circulation in Early Stages After LVAD Implantation Central and Cerebral Circulation in Early Stages After LVAD Implantation - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Central

2017 Clinical Trials

13. Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome

Nervous System Diseases Abnormalities, Multiple Congenital Abnormalities Chromosome Disorders Genetic Diseases, Inborn Obesity Overnutrition Nutrition Disorders Adrenal Gland Diseases Endocrine System Diseases Epinephrine Racepinephrine Epinephryl borate Metyrapone Adrenergic alpha-Agonists Adrenergic Agonists Adrenergic Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Adrenergic beta-Agonists Bronchodilator Agents (...) Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding

2015 Clinical Trials

14. Beta Adrenergic Receptor

. Related Studies (from Trip Database) Ontology: Receptors, Adrenergic, beta-1 (C0001642) Definition (MSH) A subclass of beta-adrenergic receptors (RECEPTORS, ADRENERGIC, BETA). The adrenergic beta-1 receptors are equally sensitive to EPINEPHRINE and NOREPINEPHRINE and bind the agonist DOBUTAMINE and the antagonist METOPROLOL with high affinity. They are found in the HEART, juxtaglomerular cells, and in the central and peripheral nervous systems. Definition (NCI) Beta 1 adrenergic receptor protein (477 (...) . Medications: Beta Adrenergics Beta Adrenergic Agonist (Beta Adrenergic Receptor) Beta Non-Specific Beta 1 Selective Prenalterol Beta 2 Selective (See ) Fenoterol Metaproterenol Beta Non-specific Pindolol Beta 1 Selective Acebutolol Alprenolol Beta 2 Selective Butoxamine Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Beta Adrenergic Receptor." Click on the image (or right click) to open the source website in a new browser window

2015 FP Notebook

15. Upregulation of Alpha-1 Receptors Upon Septic Shock?

Syndrome Inflammation Clonidine Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Antihypertensive Agents Sympatholytics Autonomic Agents Adrenergic alpha-2 Receptor Agonists Adrenergic alpha-Agonists Adrenergic Agonists Adrenergic Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action (...) Upregulation of Alpha-1 Receptors Upon Septic Shock? Upregulation of Alpha-1 Receptors Upon Septic Shock? - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Upregulation of Alpha-1 Receptors Upon Septic Shock

2013 Clinical Trials

16. A vasodilator innervation to the central artery of the rabbit ear Full Text available with Trip Pro

A vasodilator innervation to the central artery of the rabbit ear 1 The possibility of a vasodilator innervation to the isolated and perfused central artery of the rabbit ear was examined.2 Stimulation of the periarterial nerves in the presence of noradrenaline or other agonist used to maintain a partial constriction of the ear artery, led to a decrease in intraluminal flow followed after the cessation of stimulation by an increase in flow beyond the pre-stimulation level.3 After blockade (...) of adrenergic transmission with bretylium or guanethidine or of the alpha- and beta-adrenoceptors with phentolamine and propranolol, stimulation of the periarterial nerves in the presence of a background tone, led to a clearly detectable vasodilation. This dilatation was not blocked by treatment with atropine or mepyramine; nor was it enhanced by physostigmine.4 Pretreatment of rabbits with reserpine (2 mg/kg) to deplete catecholamine stores, eliminated both the vasoconstrictor and vasodilator responses

1974 British journal of pharmacology

17. Central adrenoceptors and cholinoceptors in cardiovascular control. Full Text available with Trip Pro

Central adrenoceptors and cholinoceptors in cardiovascular control. 1. In cats anaesthetized with chloralose, adrenoceptor and cholinoceptor agonists and antagonists were localized to the posterior hypothalamus (PH), lateral medullary pressor area (LMPA) and spinal autonomic loci to delineate the role of central cholinoceptors and adrenoceptors in cardiovascular control. 2 All along the neuroaxis, the alpha-adrenoceptors seem to subserve an inhibitory and the beta-adrenoceptors a facilitatory (...) role in cardiovascular control. There appear to be a predominance of alpha-adrenoceptors at the medullary level and beta-adrenoceptors at the hypothalamic level. 3 The nicotinic cholinoceptors at the hypothalamic, medullary and spinal levels were facilitatory, whereas muscarinic cholinoceptors were inhibitory for cardiovascular control. However, muscarinic receptors were undetectable at the posterior hypothalamus. 4 The central cardiovascular effects of nicotine are attributed to nicotinic receptor

1978 British journal of pharmacology

18. Effects of Anticholinergic or Long-Acting Beta 2 Agonist on FeNO and Pulmonary Function in SCI

Central Nervous System Diseases Nervous System Diseases Trauma, Nervous System Wounds and Injuries Tiotropium Bromide Salmeterol Xinafoate Cholinergic Antagonists Bronchodilator Agents Autonomic Agents Peripheral Nervous System Agents Physiological Effects of Drugs Anti-Asthmatic Agents Respiratory System Agents Parasympatholytics Cholinergic Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Adrenergic beta-2 Receptor Agonists Adrenergic beta-Agonists Adrenergic Agonists (...) breath condensates (EBC)after intervention [ Time Frame: Approx. 8 weeks ] The subject will be randomized to receive either anticholinergic agent or long acting Beta2 agonist. Measurements of EBC will take place at baseline, 1 hr post drug administration, and two weeks after intervention. Biomarkers of inflammation will be assessed by collected exhaled breath condensates, which will subsequently be sent for biochemical analysis. Markers include Isoprostane-8, TNF-Alpha, and Leukotriene B4. Pulmonary

2011 Clinical Trials

19. Effects of Adrenergic Drugs on the Fluid Balance During Surgery

infusion 0.01 µg/kg/min of the alpha-1-adrenergic receptor agonist phenylephrine Other Name: Drug by Hefeng Pharmaceutical Co, Shanghai, China. Placebo Comparator: Lactated Ringer´s solution 10 ml/h lactated Ringer's solution without active drug was infused intravenously over 3 hours. Drug: Lactated Ringer´s solution Intravenous Infusion of 10 ml/h lactated Ringer's solution that contained no drug Outcome Measures Go to Primary Outcome Measures : Urinary excretion [ Time Frame: 3 hours ] Urine (...) System Diseases Pharmaceutical Solutions Phenylephrine Oxymetazoline Adrenergic Agents Esmolol Adrenergic Agonists Cardiotonic Agents Mydriatics Autonomic Agents Peripheral Nervous System Agents Physiological Effects of Drugs Sympathomimetics Vasoconstrictor Agents Nasal Decongestants Respiratory System Agents Adrenergic alpha-1 Receptor Agonists Adrenergic alpha-Agonists Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Protective Agents Adrenergic beta-1 Receptor Antagonists

2011 Clinical Trials

20. DASH After TBI Study: Decreasing Adrenergic or Sympathetic Hyperactivity After Traumatic Brain Injury

Severe TBI TBI Catecholamines Heart rate variability Adrenergic alpha-Agonists Adrenergic beta-Antagonists Cognitive Impairment Additional relevant MeSH terms: Layout table for MeSH terms Wounds and Injuries Brain Injuries Brain Injuries, Traumatic Hyperkinesis Craniocerebral Trauma Trauma, Nervous System Brain Diseases Central Nervous System Diseases Nervous System Diseases Dyskinesias Neurologic Manifestations Signs and Symptoms Propranolol Clonidine Adrenergic Agents Adrenergic beta-Antagonists (...) Adrenergic Antagonists Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Anti-Arrhythmia Agents Antihypertensive Agents Vasodilator Agents Analgesics Sensory System Agents Peripheral Nervous System Agents Sympatholytics Autonomic Agents Adrenergic alpha-2 Receptor Agonists Adrenergic alpha-Agonists

2011 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>